|
Search
Collections
Benchmarks
Upload document
Product
HT-001
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
3 indications
Indication
Drug-induced Acneiform Eruption
Indication
Xerosis Cutis
Indication
Paronychia
Clinical trial
A Randomized, Placebo-controlled, Parallel Phase 2a Dose-ranging Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
Status: Recruiting
, Estimated PCD: 2024-12-30